Co-Diagnostics, Inc. (CODX) Financial Statements (2026 and earlier)

Company Profile

Business Address 2401 S FOOTHILL DRIVE
SALT LAKE CITY, UT 84109
State of Incorp. UT
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments29,74858,54881,26389,86347,312893
Cash and cash equivalent2,93714,91722,97488,60742,977893
Short-term investments 26,81143,63258,2891,2554,335 
Receivables1333043,52920,91412,137131
Inventory, net of allowances, customer advances and progress billings1,0731,6655,3102,0047,995197
Inventory1,0731,6655,3102,0047,995197
Prepaid expense    2,338369363
Other undisclosed current assets1,3391,6242,632 547 
Total current assets:32,29262,14192,734115,11968,3601,584
Noncurrent Assets
Operating lease, right-of-use asset2,1152,967372   
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,7613,0362,5391,933950197
Long-term investments and receivables731  75  
Long-term investments731     
Accounts and financing receivable, after allowance for credit loss    75  
Intangible asset, including goodwill, after accumulated amortization26,10126,40426,76841,902  
Goodwill    14,707  
Intangible asset, excluding goodwill, after accumulated amortization26,10126,40426,76827,195  
Other undisclosed noncurrent assets  7736731,0051,927434
Total noncurrent assets:31,70833,18030,35344,9152,877631
TOTAL ASSETS:64,00095,321123,086160,03471,2372,215
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,8563,6551,8876,6804,085207
Taxes payable2,213  
Accounts payable3,2941,4829526085986
Accrued liabilities2,5622,1739343,8603,487201
Deferred revenue41362 150305 
Due to related parties  120120
Other undisclosed current liabilities1,4181,7301,9875,767 1
Total current liabilities:7,3165,7483,87312,5984,511328
Noncurrent Liabilities
Liabilities, other than long-term debt1,2372,1522,4697,22830150
Deferred income tax liabilities   2,4187,228  
Due to related parties  30150
Operating lease, liability1,2372,15251   
Other undisclosed noncurrent liabilities 1,1361,4072,2245,733  
Total noncurrent liabilities:2,3723,5594,69312,96230150
Total liabilities:9,6889,3078,56625,5594,541478
Equity
Equity, attributable to parent54,31286,014114,520134,47566,6971,737
Preferred stock      0
Common stock383635342917
Treasury stock, value(15,576)(15,576)(14,212)   
Additional paid in capital102,47296,80888,47380,27249,15726,688
Accumulated other comprehensive income 418147293   
Retained earnings (accumulated deficit)(33,041)4,59839,93154,16917,511(24,968)
Total equity:54,31286,014114,520134,47566,6971,737
TOTAL LIABILITIES AND EQUITY:64,00095,321123,086160,03471,2372,215

Income Statement (P&L) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues3,9156,81234,21897,88674,553215
Realized investment gains8712,243    
Cost of revenue(999)(4,185)(5,481)(11,575)(16,591)(112)
Cost of product and service sold(327)(3,233)    
Other undisclosed gross profit      
Gross profit:2,9162,62728,73786,31157,961103
Operating expenses(42,997)(45,333)(55,717)(40,246)(16,268)(5,996)
Operating income (loss):(40,081)(42,706)(26,980)46,06541,694(5,894)
Nonoperating income (expense)2,5004,5968,133(429)875(302)
Investment income, nonoperating    (430)778 
Other nonoperating expense      (302)
Interest and debt expense      (106)
Income (loss) from continuing operations before equity method investments, income taxes:(37,582)(38,111)(18,847)45,63642,569(6,302)
Other undisclosed income from continuing operations before income taxes      106
Income (loss) from continuing operations before income taxes:(37,582)(38,111)(18,847)45,63642,569(6,196)
Income tax expense (benefit)(57)2,7784,609(8,977)(91) 
Income (loss) from continuing operations:(37,639)(35,333)(14,238)36,65942,479(6,196)
Income (loss) before gain (loss) on sale of properties:36,65942,479(6,196)
Net income (loss) available to common stockholders, diluted:(37,639)(35,333)(14,238)36,65942,479(6,196)

Comprehensive Income ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(37,639)(35,333)(14,238)36,65942,479(6,196)
Other comprehensive income (loss) 272(146)293   
Comprehensive income (loss):(37,367)(35,479)(13,945)36,65942,479(6,196)
Other undisclosed comprehensive loss, net of tax, attributable to parent      
Comprehensive income (loss), net of tax, attributable to parent:(37,367)(35,479)(13,945)36,65942,479(6,196)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: